Syndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca
Go back to Syndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca| (NASDAQ: SNDX) | Delayed: 20.56 -0.12 (0.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.68 | 52 Week High | $18.03 | |||
| Open | $20.46 | 52 Week Low | $8.97 | |||
| Day High | $21.00 | P/E | N/A | |||
| Day Low | $20.46 | EPS | $0.00 | |||
| Volume | 1,360,749 | |||||

